ARCHIVES

NCI, FDA Near Agreement On INDs; Young, Hoogstraten Clash On Rubidazone

This article is from The Cancer Letter archive.

Vol. 03 No. 02 | January 14, 1977

Download PDF Visit The Full Archive

Related Articles

Court Orders NIH To Retract Electronic Annotations On Fisher Publications

March 24, 1995

DCPC Board Okays Start of Low Fat High Risk Breast Cancer Study, Delays Stage 2 Trial

February 1, 1985

Panel Resumes Deliberations

January 4, 1980

In Brief: Wyeth-Ayerst To donate hormone Replacement Therapy To NIH For Women’s Health Initiative

April 23, 1993

DCCP Board Okays Concept Of Study On Black/White Survival Differences

March 5, 1982

AACR Statement on Precancers Plays Key Role in NCI Agenda

May 30, 2003